Shan Zeng, Guanghai Dai, Hairong Jiang, Ru Jia, Qun Qin, Yiping Liu, Youhong Tang, Feng Chen, Yao Xu, Jing Zhang, Qingjuan Yang, Yunhong Mei, Chunlai Mi, Qian Tang, He Li, Baiyan Liu, Siyi Zhang, Haiyong Wang, Ruiqiong Ran. "A phase I dose-escalation study of a first-in-class HIF1 and HIF2 dual inhibitor R01 in patients with advanced tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e15097